These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30710319)

  • 1. A miRNA-HERC4 pathway promotes breast tumorigenesis by inactivating tumor suppressor LATS1.
    Xu Y; Ji K; Wu M; Hao B; Yao KT; Xu Y
    Protein Cell; 2019 Aug; 10(8):595-605. PubMed ID: 30710319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WWP1 E3 ligase targets LATS1 for ubiquitin-mediated degradation in breast cancer cells.
    Yeung B; Ho KC; Yang X
    PLoS One; 2013; 8(4):e61027. PubMed ID: 23573293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice.
    Zhang Z; Tong J; Tang X; Juan J; Cao B; Hurren R; Chen G; Taylor P; Xu X; Shi CX; Du J; Hou J; Wang G; Wu D; Stewart AK; Schimmer AD; Moran MF; Mao X
    Blood; 2016 Mar; 127(13):1676-86. PubMed ID: 26825710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of E3 ligase HERC4 in breast cancer and its clinical implications].
    Zhou H; Shi R; Chen Y; Zeng W; Liang S; Zheng W; Ma W
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jul; 34(8):1110-4. PubMed ID: 25176076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2.
    Yang YL; Zhang Y; Li DD; Zhang FL; Liu HY; Liao XH; Xie HY; Lu Q; Zhang L; Hong Q; Dong WJ; Li DQ; Shao ZM
    Cell Death Differ; 2020 Mar; 27(3):1105-1118. PubMed ID: 31406303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The miR-1185-2-3p-GOLPH3L pathway promotes glucose metabolism in breast cancer by stabilizing p53-induced SERPINE1.
    Xu Y; Chen W; Liang J; Zeng X; Ji K; Zhou J; Liao S; Wu J; Xing K; He Z; Yang Y; Liu Q; Zhu P; Liu Y; Li L; Liu M; Chen W; Huang W
    J Exp Clin Cancer Res; 2021 Jan; 40(1):47. PubMed ID: 33509226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HERC4 Is Overexpressed in Hepatocellular Carcinoma and Contributes to the Proliferation and Migration of Hepatocellular Carcinoma Cells.
    Zheng Y; Li J; Pan C; Zhou G; Zhuge L; Jin L; Fang P
    DNA Cell Biol; 2017 Jun; 36(6):490-500. PubMed ID: 28430527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HERC4 exerts an anti-tumor role through destabilizing the oncoprotein Smo.
    Sun X; Sun B; Cui M; Zhou Z
    Biochem Biophys Res Commun; 2019 Jun; 513(4):1013-1018. PubMed ID: 31010679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability [corrected].
    Ho KC; Zhou Z; She YM; Chun A; Cyr TD; Yang X
    Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4870-5. PubMed ID: 21383157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity.
    Salah Z; Melino G; Aqeilan RI
    Cancer Res; 2011 Mar; 71(5):2010-20. PubMed ID: 21212414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis.
    Zhao D; Zhi X; Zhou Z; Chen C
    Carcinogenesis; 2012 Jan; 33(1):59-67. PubMed ID: 22045023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressor role of cytoplasmic polyadenylation element binding protein 2 (CPEB2) in human mammary epithelial cells.
    Tordjman J; Majumder M; Amiri M; Hasan A; Hess D; Lala PK
    BMC Cancer; 2019 Jun; 19(1):561. PubMed ID: 31185986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippo Stabilises Its Adaptor Salvador by Antagonising the HECT Ubiquitin Ligase Herc4.
    Aerne BL; Gailite I; Sims D; Tapon N
    PLoS One; 2015; 10(6):e0131113. PubMed ID: 26125558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression and clinical significance of HERC4 in breast cancer.
    Zhou H; Shi R; Wei M; Zheng WL; Zhou JY; Ma WL
    Cancer Cell Int; 2013 Nov; 13(1):113. PubMed ID: 24225229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WWP2 drives the progression of gastric cancer by facilitating the ubiquitination and degradation of LATS1 protein.
    Zou J; Zhou L; Le Y; Fang Z; Zhong M; Nie F; Wei X; Zhang X; Chen Z; Cai L; Wang H; Xiong J; Fang Z; Xiang X
    Cell Commun Signal; 2023 Feb; 21(1):38. PubMed ID: 36803368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylation Stabilizes Phosphoglycerate Dehydrogenase by Disrupting the Interaction of E3 Ligase RNF5 to Promote Breast Tumorigenesis.
    Wang C; Wan X; Yu T; Huang Z; Shen C; Qi Q; Xiang S; Chen X; Arbely E; Ling ZQ; Liu CY; Yu W
    Cell Rep; 2020 Aug; 32(6):108021. PubMed ID: 32783943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Expression of MicroRNA 551a by c-Fos Reduces Focal Adhesion Kinase Levels and Blocks Tumorigenesis.
    Anuj ; Arivazhagan L; Venkatraman G; Rayala SK
    Mol Cell Biol; 2019 Apr; 39(7):. PubMed ID: 30670568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis.
    Ren C; Yang T; Qiao P; Wang L; Han X; Lv S; Sun Y; Liu Z; Du Y; Yu Z
    Mol Oncol; 2018 May; 12(5):690-704. PubMed ID: 29570932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
    Wu H; Li J; Guo E; Luo S; Wang G
    Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HERC4 modulates ovarian cancer cell proliferation by regulating SMO-elicited hedgehog signaling.
    Zhu Q; Yang X; Lv Y
    Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130557. PubMed ID: 38181892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.